首页 齐默巴奥米特控股(usZBH)-基本信息

齐默巴奥米特控股(usZBH)-基本信息

日报更新时间:

周报更新时间:04-18 04:06

行情信息

今开价:174.04

最高价:177.22

成交量:462852.0

昨收价:173.81

最低价:173.37

最新价:176.325

行情图标
概要信息

中文名称:齐默巴奥米特控股


英文名称:Zimmer Biomet


简介:齐默巴奥米特控股公司是肌肉骨骼保健的全球领导者。他们设计,生产和销售骨科重建产品;运动医学,生物制剂,四肢和创伤产品;脊椎,骨愈合,颅颌面,胸产品;牙种植体;及相关外科产品


电话:1-574-2676131


最新量化综合结论
百科信息
  • 相关网站
  • 百科
  • 员工交易记录
  • 持股信息
  • 领导人信息

Zimmer Biomet Holdings Inc.前身为Zimmer Holdings, Inc.,原为Bristol-Myers Squibb Company旗下子公司,2001年自Bristol-Myers Squibb分拆后于纽约证交所上市(原齐默尔控股,NYSE:ZMH),2015年6月24日,Zimmer Holdings完成了以134亿美金收购Biomet Inc.的交易,更名为,Zimmer Biomet Holdings Inc.。Zimmer Biomet主要连同其子公司在美洲、欧洲及亚太地区从事设计、开发、制造及行销骨科重建装置、脊柱及创伤设备、生物制剂、牙科植体和相关手术产品。Zimmer Biomet公司提供因疾病或创伤造成功能损失修复的骨科重建装置,包括膝、髋骨、肩及肘等关节;因创伤或疾病造成牙齿脱落的牙科重建植入物,可修复其功能及美观;脊柱设备则是让骨科外科医师和神经外科医师用于治疗各脊柱部位的退化性疾病、畸形和创伤;创伤设备主要用于重新连接或稳定受损的骨和组织,借以支撑身体自然愈合的过程。此外,Zimmer Biomet公司也提供相关手术产品,例如骨科手术程序和术后复原的辅助手术用品及器具;及其他医疗相关服务。Zimmer Biomet公司主要服务骨科外科医师、神经外科医师、口腔医师、牙医师、医院、经销商、医疗代理商、以及代理商、医疗采购组织或团购。Zimmer Biomet Holdings(ZBH)收购历史:第一部分:Zimmer, Inc收购历史 2003年,收购Centerpulse AG; 2003年,收购InCentive Capital AG; 2007年,收购ORTHOsoft Inc; 2011年11月,收购ExtraOrtho, Inc.; 2012年1月,收购Synvasive Technology, Inc.; 2013年,收购Medizin-Technik GmbH; 2013年,收购Knee Creations, LLC; 2014年,收购ETEX Holdings, Inc。第二部分:Biomet, Inc收购历史 1984年,收购Orthopaedic Equipment Company; 1988年,收购Electro-Biology, Inc; 1990年,收购Arrow Surgical Technologies,并将其更名为Biomet Sports Medicine; 1992年,收购W. Lorenz Surgical, Inc; 1994年,收购Kirschner Medical Corporation; 1999年,收购Innovations, Inc; 2004年,收购Merck KGaA。第三部分:Zimmer Biomet Holdings Inc. 2015年6月24日,Zimmer Holdings完成了以134亿美金收购Biomet Inc.的交易; 2015年6月29日,公司更名为Zimmer Biomet Holdings Inc.,启用新股票代码:ZBH。

交易日期 交易人 职位 类型 交易份额 价格
2017-07-30 Collins (Tony W) Officer Sell 15096 121.71
2017-07-30 Collins (Tony W) Officer Sell 1200 122.38
2017-07-30 Collins (Tony W) Officer Buy 2670 104.01
2017-07-30 Collins (Tony W) Officer Sell 597 121.32
2017-07-30 Collins (Tony W) Officer Buy 4723 113.83
2017-07-30 Collins (Tony W) Officer Sell 93 121.76
2017-07-30 Collins (Tony W) Officer Buy 1752 73.15
2017-07-30 Collins (Tony W) Officer Buy 4723 113.83
2017-07-30 Collins (Tony W) Officer Buy 2428 94.34
2017-06-23 Williamson (Daniel E) Officer Buy 10565 --
2017-06-23 Florin (Daniel P) Chief Financial Officer Buy 16225 --
2017-06-23 Florin (Daniel P) Chief Financial Officer Sell 7262 129.26
2017-06-23 Williamson (Daniel E) Officer Sell 4283 129.26
2017-06-23 Johnson (Adam Rudolph) Officer Buy 10565 --
2017-06-23 Johnson (Adam Rudolph) Officer Sell 3489 129.26
2017-06-11 Yi (Sang) Officer Sell 4300 123.62
2017-06-08 Yi (Sang) Officer Sell 3550 124.86
2017-06-08 Yi (Sang) Officer Buy 6097 73.15
2017-06-08 Yi (Sang) Officer Sell 6097 124.86
2017-06-08 Yi (Sang) Officer Buy 3310 94.34
2017-06-08 Yi (Sang) Officer Buy 3550 74.90
2017-06-08 Yi (Sang) Officer Sell 3310 124.86
2017-06-08 Yi (Sang) Officer Sell 474 124.93
2017-05-04 PHIPPS CHAD F General Counsel Sell 5000 116.62
2017-05-04 PHIPPS CHAD F General Counsel Sell 1200 117.34
2017-05-04 PHIPPS CHAD F General Counsel Buy 6200 90.61
2017-04-26 Dvorak (David C) Chief Executive Officer Buy 100000 88.76
2017-04-26 Dvorak (David C) Chief Executive Officer Sell 34547 116.99
2017-04-26 Dvorak (David C) Chief Executive Officer Sell 52784 116.13
2017-03-31 Yi (Sang) Officer Buy 400 --
第 页, 共 4 页 首页 上页 下页 末页

机构持股
持有者 持有份额 持股比例 份额变化 变化率 报告日期
PRIMECAP Management Company 2463720 1.20% 559370 29.37% 2019-03-31
BlackRock Fund Advisors 5563842 2.72% -218676 -3.78% 2019-07-31
Vanguard Investments Australia Ltd 5709799 2.79% 37769 0.67% 2019-07-31
T. Rowe Price Associates, Inc. 5877198 2.87% 619098 11.77% 2019-03-31
State Street Corporation 8515264 4.16% 397103 4.89% 2019-03-31
Massachusetts Financial Services Company 12149410 5.93% -1789742 -12.84% 2019-03-31
MFS Investment Management KK 12149410 5.93% -1789742 -12.84% 2019-03-31
Vanguard Group Inc 15308235 7.47% 266366 1.77% 2019-03-31
BlackRock Inc 16474877 8.04% 509160 3.19% 2019-03-31
American Century Companies Inc 4650137 2.27% -775482 -14.29% 2019-03-31
J.P. Morgan Investment Management, Inc. 4540383 2.22% -807346 -15.10% 2019-07-31
Wellington Management Company LLP 4241424 2.07% -57808 -1.34% 2019-03-31
Geode Capital Management, LLC 2809132 1.37% -2474302 -46.83% 2019-03-31
Nordea Investment Mgmt Bank Demark A/s 3073845 1.50% -8184543 -72.70% 2019-03-31
OppenheimerFunds Inc 3156333 1.54% 231307 7.91% 2019-03-31
State Street Global Advisors 3345137 1.63% 8962 0.27% 2019-07-31
American Century Investment Management, Inc 3498030 1.71% -258957 -6.89% 2019-07-31
Invesco Advisers, Inc. 3511567 1.71% -339483 -8.82% 2019-07-31
Northern Trust Corp 3598599 1.76% 8040 0.22% 2019-03-31
Northern Trust Investments N A 3598599 1.76% 8040 0.22% 2019-03-31
Amvescap Plc. 5113860 2.50% 185151 3.76% 2018-12-31
BlackRock Asset Management Canada Ltd 6413292 3.13% 8158 0.13% 2019-05-31
BlackRock Japan Co Ltd 3026170 1.48% 2981270 6639.80% 2019-04-30
Longview Partners (Guernsey) Ltd. 6451025 3.15% -118149 -1.80% 2018-12-31
JPMorgan Chase & Co 11595444 5.67% 1033717 9.79% 2018-09-30
TIAA-CREF Investment Management LLC 5380036 2.63% 2928200 119.43% 2018-09-30
Nordea Investment Management AB 2913355 1.43% 6522 0.22% 2018-12-31
Fidelity Management & Research Company 2974416 1.46% -93028 -3.03% 2018-11-30
Invesco Advisers, Inc 3570228 1.75% 78846 2.26% 2018-06-30
BlackRock Institutional Trust Company NA 4901208 2.40% -565666 -10.35% 2018-06-30
State Street Corp 7586135 3.73% -198765 -2.55% 2018-06-30
American Century Inv Mgt Inc 4849013 2.38% -190168 -3.77% 2018-06-30
J.P. Morgan Investment Management Inc 7421744 3.65% 585865 8.57% 2018-06-30
JANA Partners LLC 2849125 1.40% -261545 -8.41% 2018-06-30
State Street Global Advisors (Aus) Ltd 2327526 1.14% 54540 2.40% 2018-09-12
Nordea Inv Management AB, Copenhagen 2554968 1.25% -267582 -9.48% 2018-07-31
Fidelity Management and Research Company 2275075 1.12% -338413 -12.95% 2018-06-30
Healthcor Management LP 1925000 0.95% -400000 -17.20% 2018-06-30
Wells Capital Management Inc. 1571301 0.77% 88445 5.96% 2018-03-31
NORGES BANK 1691877 0.84% -678159 -28.61% 2017-12-31
Goldman Sachs Asset Management LP 1559649 0.77% 832112 114.37% 2017-12-31
Invesco Canada Fund Inc 1547462 0.76% -16461 -1.05% 2017-12-31
J. P. Morgan Chase Bank NA 1527296 0.75% 952378 165.65% 2017-12-31
BlackRock Advisors LLC 2369599 1.17% -147866 -5.87% 2018-02-28
Columbia Mangmt Investment Advisers, LLC 2004656 0.99% -1046650 -34.30% 2017-09-30
MFS Investment Management K.K. 16684779 8.24% -3304258 -16.53% 2017-12-31
Glenview Capital Management LLC 3155386 1.56% 2383976 309.04% 2017-09-30
Winslow Capital Management, LLC 2732842 1.37% 157563 6.12% 2016-09-30
First Manhattan Company 2565370 1.28% 22763 0.90% 2016-09-30
AllianceBernstein LP 2329756 1.16% 726340 45.30% 2016-09-30
Eaton Vance Management 2161922 1.08% 806843 59.54% 2016-09-30
Investec Asset Management Ltd 2114021 1.06% 2677 0.13% 2016-09-30
Robeco Investment Management, Inc. 2098348 1.05% -1267531 -37.66% 2016-09-30
The Vanguard Group 8828785 1.00% 1031113800 -- 1999-11-30
BlackRock, Inc. 11184659 1.00% 1306256325 0.10% 1999-11-30
FMR, LLC 11579992 1.00% 1352427266 0.10% 1999-11-30
共同基金持股
持有者 持有份额 持股比例 份额变化 变化率 报告日期
JHancock Disciplined Value Fund 879930 0.43% 879930 -- 2019-05-31
JPMorgan Mid Cap Value Fund 1744733 0.85% -- -- 2019-06-30
Vanguard Institutional Index Fund 1912312 0.93% -9819 -0.51% 2019-06-30
American Century Mid Cap Value Fund 1946138 0.95% 176557 9.98% 2019-06-30
CREF Stock Account 2256666 1.10% 511861 29.34% 2019-06-30
SPDR 2269966 1.11% -6273 -0.28% 2019-07-31
Vanguard Health Care Fund 2771941 1.35% 195200 7.58% 2019-03-31
Vanguard 500 Index Fund 4028818 1.97% 48512 1.22% 2019-06-30
Vanguard Total Stock Market Index Fund 5628992 2.75% 37961 0.68% 2019-06-30
Fidelity 1658428 0.81% 27378 1.68% 2019-06-30
iShares Core S&P 500 ETF 1504710 0.73% -744 -0.05% 2019-07-30
Vanguard Value Index Fund 1302119 0.64% -15431 -1.17% 2019-06-30
State Street S&P 500 Index Fund 885695 0.43% 13600 1.56% 2019-07-31
iShares US Medical Devices ETF 888803 0.43% 5590 0.63% 2019-07-30
Vanguard PrimeCap Fund 984200 0.48% 227200 30.01% 2019-03-31
Wells Fargo Special Mid Cap Value Fund 1019900 0.50% -- -- 2019-06-30
Invesco Equity and Income Fund 1036315 0.51% -- -- 2019-06-30
Health Care Select Sector SPDR 1037145 0.51% 8220 0.80% 2019-07-31
T. Rowe Price Mid-Cap Value Fund 1212000 0.59% 10700 0.89% 2019-06-30
Virtus Ceredex Mid-Cap Value Equity Fund 1270000 0.62% 30000 2.42% 2019-06-30
JPMorgan US Large Cap Core Plus Fund 1102463 0.54% -81449 -6.88% 2019-05-31
T. Rowe Price Value Fund 1134700 0.55% -5200 -0.46% 2019-03-31
BlackRock Health Sciences Opps Port 984800 0.48% -- -- 2019-05-31
iShares Core MSCI Kokusai ETF 1510737 0.74% 1353 0.09% 2019-05-30
iShares Core S&P US Total Market ETF 1510737 0.74% 1353 0.09% 2019-05-30
iShares Core S&P 500 ETF (CAD-Hedged) 1510737 0.74% 1353 0.09% 2019-05-30
iShares S&P 500 ETF 1510737 0.74% 1353 0.09% 2019-05-30
iShares MSCI World ETF 1504956 0.73% 492 0.03% 2019-05-23
iShares Core MSCI AllCntry Wld exCan ETF 1504956 0.73% 492 0.03% 2019-05-23
Undrly L&G Diversified Life 885514 0.43% 885514 -- 2018-09-30
Oppenheimer Main Street Fund 921880 0.45% 147920 19.11% 2019-02-28
Undrly L&G Pen PMC Diversified 885514 0.43% 885514 -- 2018-09-30
JPMCB U.S. Active Core Plus Equity Fund 872034 0.43% 48870 5.94% 2018-12-31
Invesco Growth and Income Fund 825287 0.40% 74972 9.99% 2018-12-31
OH Putnam Fidelity Spartan 500 Index 1528099 0.75% 44216 2.98% 2019-01-31
BlackRock Basic Value Fund 726917 0.36% 21440 3.04% 2018-11-30
BlackRock Global Allocation Fund 793603 0.39% -293778 -27.02% 2018-04-30
Nomura Insight Euro Bond Mother 1550000 0.76% 1550000 -- 2018-01-22
Vanguard Total Stock Mkt Idx 5104840 2.51% 24232 0.48% 2018-07-31
Vanguard 500 Index Inv 3681637 1.81% 5650 0.15% 2018-07-31
Vanguard Health Care Inv 2447976 1.20% 2447976 -- 2018-06-30
CREF Stock R1 2125643 1.04% 179983 9.25% 2018-07-31
Vanguard Institutional Index I 1966979 0.97% 3180 0.16% 2018-07-31
American Century Mid Cap Value Inv 2168361 1.07% 168698 8.44% 2018-06-30
JPMorgan Mid Cap Value Instl 1787812 0.88% -- -- 2018-07-31
Fidelity Spartan 1354028 0.67% 15973 1.19% 2018-07-31
Wells Fargo Special Mid Cap Value Inst 1164800 0.57% -- -- 2018-07-31
JPMorgan US Large Cap Core Plus A 1158209 0.57% -13314 -1.14% 2018-07-31
Vanguard Value Index Inv 1128538 0.55% 26135 2.37% 2018-07-31
T. Rowe Price Mid-Cap Value 1066200 0.52% 31800 3.07% 2018-06-30
RidgeWorth Mid-Cap Value Equity C 835000 0.41% 5000 0.60% 2018-07-31
Invesco Equity and Income A 933065 0.46% 35633 3.97% 2018-06-30
BlackRock Basic Value Instl 757986 0.37% -21270 -2.73% 2018-07-31
iShares US Medical Devices 712495 0.36% 2639 0.37% 2018-09-12
BlackRock Global Allocation Inv B 793603 0.39% -293778 -27.02% 2018-04-30
Oppenheimer Global A 925744 0.46% -- -- 2018-06-30
Mairs & Power Growth Inv 745000 0.37% -- -- 2018-03-31
MFS Mid Cap Value A 630022 0.31% -- -- 2017-12-31
iShares Russell 1000 Value 617214 0.32% -495 -0.08% 2018-01-24
Ariel Appreciation Investor 644700 0.32% -- -- 2017-09-30
Columbia Contrarian Core Z 983950 0.49% -263200 -21.10% 2016-12-31
MFS Massachusetts Investors Gr Stk A 851860 0.43% -12389 -1.43% 2016-12-31
Goldman Sachs Mid Cap Value Instl 669110 0.33% 189725 39.58% 2016-12-31
JHancock Disciplined Value Mid Cap A 616536 0.31% 10274 1.69% 2016-12-31
SPDR® S&P 500® ETF Trust 1567700 0.80% -- -- 2015-09-30
Fidelity® Low-Priced Stock Fund 1149044 0.60% -36922 -3.10% 2015-07-31
Goldman Sachs Mid Cap Value Fund 1129482 0.60% -- -- 2015-09-30
Oppenheimer Global Fund 1047054 0.50% 3030 0.30% 2015-09-30
Fidelity® Contrafund® Fund 954056 0.50% -959628 -50.10% 2015-09-30
JHancock Disciplined Value Mid Cap Fund 896703 0.40% -197438 -18.10% 2015-09-30
Health Care Select Sector SPDR® Fund 881097 0.40% -2383 -0.30% 2015-11-19
Fidelity Spartan® 500 Index Fd 840484 0.40% 2791 0.30% 2015-09-30
SPDR® S&P 500 ETF 1641795 0.80% 12513 0.80% 2015-11-19

Arthur Joseph Higgins Founder of Ascendancy Healthcare, Inc., Arthur Joseph Higgins is a businessperson who has been the head of 9 different companies and is President, Chief Executive Officer & Director at Assertio Therapeutics, Inc. Mr. Higgins is also on the board of Ecolab, Inc., Zimmer Biomet Holdings, Inc., Nuvelution Pharma, Inc. and Zimmer US, Inc. In the past Mr. Higgins held the position of Executive Chairman for Ascendancy Healthcare, Inc., Chairman, President & Chief Executive Officer for Enzon Pharmaceuticals, Inc., Independent Director at Resverlogix Corp., Vice President of Bristol-Myers Squibb Co., President-Pharmaceutical Products Division at Abbott Laboratories, Chairman at Bayer Pharma AG, Chairman for Bayer Schering Pharma AG, Chairman-Management Board at Bayer HealthCare AG, Chairman & Chief Executive Officer for Bayer Healthcare LLC, Member of Blackstone Healthcare Partners LLC, Principal at Sandoz, Inc., Principal at Fisons Ltd., Chairman at Biotechnology Council of New Jersey, Inc., President of European Federation of Pharmaceutical Industries & Assns, Chairman-Biotechnology Council at National Pharmaceutical Council and Council Member at International Federation of Pharmaceutical Manufacturers. He received an undergraduate degree from the University of Strathclyde.
Betsy J. Bernard Betsy J. Bernard is a businessperson who has been the head of 5 different companies. Ms. Bernard is Advisor at Grotech Ventures and on the board of 5 other companies. She previously held the position of Principal at AVIRNEX Communications Group, Non-Executive Chairman at Telular Corp., Chief Executive Officer & Executive Vice President at AT&T Consumer Services, President & Chief Executive Officer of Pacific Telesis Group, President of AT&T Business Services, President for AT&T Corp., Executive Vice President-Retail at US West, Inc., Executive Vice President-National Mass Markets at Qwest Communications International, Inc. and Principal at Pacific Bell Telephone Co. She received an undergraduate degree from St. Lawrence University, an MBA from Fairleigh Dickinson University and a graduate degree from Stanford University.
Gail Koziara Boudreaux Ms. Gail K. Boudreaux is a President & Chief Executive Officer at Anthem, Inc., and an Independent Director at Zimmer Biomet Holdings, Inc. She is on the Board of Directors at Anthem, Inc., Anthem, Inc., Zimmer Biomet Holdings, Inc., Zimmer US, Inc., America's Health Insurance Plans, Inc., Dental Network of America, Inc., HCSC Insurance Services Co., Health Services Foundation, National Institute for Health Care Management Foundation, The Business Roundtable, The Central Indiana Corporate Partnership, Dartmouth College and The Field Museum of Natural History. Ms. Boudreaux was previously employed as an Independent Director by Novavax, Inc., a Chief Executive Officer by GKB Global Health LLC, an Independent Director by Xcel Energy, Inc., a Chief Executive Officer by United Healthcare Corp., a President by United HealthCare Services, Inc., an Executive Vice President by UnitedHealth Group, Inc., a President by Blue Cross & Blue Shield of Illinois, an Executive Vice President-External Operations by Health Care Service Corp., a Senior Vice President-Group Insurance Business by Aetna, Inc., an Executive Vice President by Colorado Bankers Life Insurance Co., and an Executive Vice President by Fort Dearborn Life Insurance Co. She also served on the board at Genzyme Corp. and Zimmer Corp. She received her undergraduate degree from Dartmouth College and an MBA from Columbia Business School.
Chad F. Phipps Chad F. Phipps holds the position of Secretary, Senior Vice President & General Counsel of Zimmer Biomet Holdings, Inc. and Secretary, Senior Vice President & General Counsel of Zimmer, Inc., Secretary, Director & Senior Vice President at LDR Holding Corp. and Secretary of Biomet, Inc. (which are all subsidiaries of Zimmer Biomet Holdings, Inc.). He is also on the board of Cayenne Medical, Inc. Chad F. Phipps previously occupied the position of Vice President & General Counsel of L&N Sales & Marketing, Inc. He received an undergraduate degree from Rollins College (Florida) and a graduate degree from Villanova University School of Law.
Derek M. Davis Presently, Derek M. Davis occupies the position of Vice President-Global Integration at Zimmer Biomet Holdings, Inc. In his past career Mr. Davis held the position of Vice President-Finance & Controller at International Wire Group Holdings, Inc., Chief Accounting Officer, VP-Finance & Controller at Zimmer, Inc. and Senior Financial Analyst at Phelps Dodge Corp. Mr. Davis received an undergraduate degree and an MBA from Indiana University.
Michael J. Farrell Presently, Michael J. Farrell occupies the position of Chief Executive Officer & Director at ResMed, Inc. and Chief Executive Officer of ResMed (UK) Ltd. (a subsidiary of ResMed, Inc.). He is also on the board of 9 other companies. In his past career he occupied the position of Process Engineer at BHP Group Ltd., Manager-Chemicals Practice at Arthur D. Little, Inc., Consultant & Business Analyst at Genzyme Corp. and Principal at The Dow Chemical Co. Mr. Farrell received an undergraduate degree from The University of New South Wales, a graduate degree from Massachusetts Institute of Technology and an MBA from MIT Sloan School of Management.
Bryan C. Hanson Currently, Bryan C. Hanson occupies the position of President, Chief Executive Officer & Director at Zimmer Biomet Holdings, Inc. and President of United States Surgical Corp. He is also on the board of AmeriCares Foundation, Inc. In the past he occupied the position of Group President at Medtronic Plc and Group President at Covidien Plc (a subsidiary of Medtronic Plc). He received an undergraduate degree from Florida State University.
Robert A. Hagemann Robert A. Hagemann is on the board of Ryder System, Inc. and 4 other companies. He previously was Chief Financial Officer & Senior Vice President for Quest Diagnostics, Inc. and Vice President & Controller for Corning Life Sciences, Inc. (a subsidiary of Quest Diagnostics, Inc.), Principal at Merrill Lynch & Co., Inc., Principal at Ernst & Young LLP, Principal at Crompton & Knowles Corp. and Principal at Prime Hospitality Corp. Robert A. Hagemann received an undergraduate degree from Rider University and an MBA from Seton Hall University.
Michael W. Michelson Mr. Michael W. Michelson is a Member at KKR Management LLC and Member of Private Equity at Kohlberg Kravis Roberts & Co. LP. He is on the Board of Directors at Zimmer Biomet Holdings, Inc. and Zimmer Biomet, Inc. Mr. Michelson was previously employed as a Principal by Latham & Watkins LLP. He also served on the board at Biomet, Inc., HCA, Inc., Accellent Inc., Jazz Pharmaceuticals, Inc., Alliance Imaging, Inc., Alliance HealthCare Services, Inc., Amphenol Corp., HCA Holdings, Inc. and OWENS ILLINOIS HOLDINGS CORP. He received his undergraduate degree from Harvard College and a graduate degree from Harvard Law School.
Larry C. Glasscock Larry C. Glasscock is a businessperson who has been at the helm of 8 different companies. Presently, he is Non-Executive Chairman at Zimmer Biomet Holdings, Inc. and Chairman for Zimmer US, Inc. (a subsidiary of Zimmer Biomet Holdings, Inc.). He is also on the board of 8 other companies. In his past career he occupied the position of Non-Executive Chairman at Anthem, Inc. Chairman, President & Chief Executive Officer at Anthem, Inc. and President & Chief Executive Officer at Anthem Insurance Cos., Inc. (both are subsidiaries of Anthem, Inc.), Group Executive Vice President-Corporate Banking at Ameritrust Corp., President & Chief Executive Officer of Essex Holding, Inc., President & Chief Operating Officer for First American Bank, NA (Hudson, Wisconsin) and Chief Operating Officer of CareFirst, Inc. He received an undergraduate degree from Cleveland State University.
Christopher B. Begley Currently, Christopher B. Begley occupies the position of Non-Executive Chairman of Hanger, Inc. Mr. Begley is also on the board of Zimmer Biomet Holdings, Inc., The Executives Club of Chicago, Association for Accessible Medicines and Zimmer US, Inc. In the past he occupied the position of Chairman of Adtalem Global Education, Inc., Senior Vice President-Hospital Products at Abbott Laboratories and Vice President at MediSense, Inc. (a subsidiary of Abbott Laboratories), Non-Executive Chairman of The Hillshire Brands Co., Executive Chairman of Hospira, Inc., Vice President-V Mueller Division Marketing at American Hospital Supply Corp. and Member-Civic Committee at Commercial Club Foundation. Christopher B. Begley received an undergraduate degree from Western Illinois University and an MBA from Northern Illinois University.
Coleman N. Lannum Coleman N. Lannum is Senior Vice President-Investor Relations at Zimmer Biomet Holdings, Inc. In his past career Mr. Lannum occupied the position of Senior Vice President-Investor Strategy at Mallinckrodt Plc and Head-Investor Relations of Mallinckrodt, Inc.(Old) (a subsidiary of Mallinckrodt Plc), Vice President & Investor Relations Officer at Tyco Healthcare (Illinois), SVP-Strategy & Investor Relations Officer at Mallinckrodt Pharmaceuticals, Senior Investment Officer at Boatmen's Trust Co. (Missouri), Vice President & Senior Portfolio Manager at Putnam Investments (Ireland) Ltd., Portfolio Manager at Putnam LLC, Vice President-Investor Relations at Covidien New Zealand Ltd., Vice President-Investor Relations for Covidien Plc and Vice President-Investor Relations for Covidien Holding, Inc. Coleman N. Lannum received an MBA from Texas A&M University and an undergraduate degree from Washington University in St. Louis.
Robert A. Hagemann Robert A. Hagemann is on the board of Ryder System, Inc. and 4 other companies. He previously was Chief Financial Officer & Senior Vice President for Quest Diagnostics, Inc. and Vice President & Controller for Corning Life Sciences, Inc. (a subsidiary of Quest Diagnostics, Inc.), Principal at Merrill Lynch & Co., Inc., Principal at Ernst & Young LLP, Principal at Crompton & Knowles Corp. and Principal at Prime Hospitality Corp. Robert A. Hagemann received an undergraduate degree from Rider University and an MBA from Seton Hall University.
Maria Teresa Hilado Maria Teresa Hilado holds the position of Director & Vice President at Kythera Biopharmaceuticals LLC. Ms. Hilado is also Co-Chairman-Strong Kids Campaign at YMCA of Greater New York and on the board of 5 other companies. In her past career she was Chief Financial Officer of Ally Financial, Inc. and Chief Financial Officer of Ally Commercial Finance LLC (a subsidiary of Ally Financial, Inc.), Chief Financial Officer at Allergan Plc Chief Financial Officer at Actavis, Inc. and Chief Financial Officer of Allergan, Inc. (both are subsidiaries of Allergan Plc), Treasurer & Senior Vice President at PepsiCo, Inc., Assistant Treasurer at General Motors Corp. and Treasurer & Vice President of Schering-Plough Corp. Ms. Hilado received an undergraduate degree from the University of Ateneo de Manila and an MBA from the University of Virginia Darden School of Business.
Daniel P. Florin Presently, Daniel P. Florin is EVP, Chief Financial & Accounting Officer at Zimmer Biomet Holdings, Inc. and President of Biomet, Inc., President at BIOMET 3i LLC and Director & Senior Vice President at LDR Holding Corp. (which are all subsidiaries of Zimmer Biomet Holdings, Inc.). Mr. Florin is also on the board of Cayenne Medical, Inc. and Zimmer Biomet Robotics. In the past he held the position of Vice President & Controller of Boston Scientific Corp. and Chief Financial Officer & Senior Vice President of Biomet Biologics LLC. Daniel P. Florin received an undergraduate degree from the University of Notre Dame and an MBA from Boston University.
Betsy J. Bernard Betsy J. Bernard is a businessperson who has been the head of 5 different companies. Ms. Bernard is Advisor at Grotech Ventures and on the board of 5 other companies. She previously held the position of Principal at AVIRNEX Communications Group, Non-Executive Chairman at Telular Corp., Chief Executive Officer & Executive Vice President at AT&T Consumer Services, President & Chief Executive Officer of Pacific Telesis Group, President of AT&T Business Services, President for AT&T Corp., Executive Vice President-Retail at US West, Inc., Executive Vice President-National Mass Markets at Qwest Communications International, Inc. and Principal at Pacific Bell Telephone Co. She received an undergraduate degree from St. Lawrence University, an MBA from Fairleigh Dickinson University and a graduate degree from Stanford University.
Rachel H. Ellingson Rachel H. Ellingson is on the board of American Heart Association, Inc. and LifeScience Alley and President at St. Jude Medical Foundation and Senior Vice President-Strategy at Zimmer Biomet Holdings, Inc. Ms. Ellingson previously occupied the position of Managing Director at Bank of America Corp., Vice President-Corporate Strategy at St. Jude Medical LLC, VP-Business Development & Investor Relations at AGA Medical Holdings, Inc. and VP-Business Development & Investor Relations at AGA Medical Corp. Ms. Ellingson received an undergraduate degree from the University of Rhode Island and an MBA from the University of Connecticut.
Robert J. Marshall Currently, Robert J. Marshall is Chief Financial Officer & Treasurer at Lantheus Holdings, Inc. and Treasurer for Zimmer Biomet Holdings, Inc. In his past career he held the position of Treasurer & Vice President-Investor Relations at Zimmer, Inc. He received an MBA from Indiana University and an undergraduate degree from the University of Notre Dame.
Suketu P. Upadhyay Presently, Suketu P. Upadhyay holds the position of Chief Financial Officer, Director & Executive VP at Auxilium Pharmaceuticals LLC. In his past career Mr. Upadhyay held the position of CFO, Controller & Senior Vice President-Finance at Becton, Dickinson & Co., Chief Financial Officer & Executive Vice President of Endo International Plc and Chief Financial Officer & Executive Vice President for Endo Health Solutions, Inc. (a subsidiary of Endo International Plc), Principal at Johnson & Johnson, Principal at KPMG LLP and Principal at AstraZeneca LP. He received an undergraduate degree from Albright College and an MBA from The Fuqua School of Business.
William P. Fisher Currently, William P. Fisher holds the position of Senior Vice President-Global Human Resources at Zimmer Biomet Holdings, Inc. Mr. Fisher previously held the position of Vice President-Human Resources for Meritor, Inc., Senior Director-Human Resources at General Electric Co. and Senior Human Resources Leader at GE Healthcare, Inc. (a subsidiary of General Electric Co.), Senior Director-Human Resources at GE Plastics and Senior Vice President-Global Human Resources at Zimmer, Inc. Mr. Fisher received an undergraduate degree from Cornell University, an MBA from Indiana University and a graduate degree from Eastern Michigan University.
Jeffrey K. Rhodes Mr. Jeffrey K. Rhodes is Partner at TPG Capital Management LP. He is on the Board of Directors at Zimmer Biomet Holdings, Inc., Zimmer Biomet, Inc., Surgical Care Affiliates, Inc., Immucor, Inc., Surgical Care Affiliates LLC, Envision Pharmaceutical Holdings, Inc., Envision Pharmaceutical Services LLC and Par Pharmaceutical Cos., Inc. Mr. Rhodes was previously employed as Partner by TPG Global LLC, Vice President-Business Development by Article 27 Ltd., and Engagement Manager by McKinsey & Co., Inc. He also served on the board at Biomet, Inc., QuintilesIMS. Inc., IMS Health Holdings, Inc. and Healthcare Private Equity Association. Mr. Rhodes received his undergraduate degree from Williams College and an MBA from Harvard Business School.
Daniel E. Williamson Daniel E. Williamson is on the board of Medtech SAS and Group President-Joint Reconstruction at Zimmer Biomet Holdings, Inc. In his past career he occupied the position of Vice President for Interpore Spine Ltd. and President-Global Reconstructive Joints & Senior VP at Biomet, Inc. Daniel E. Williamson received an undergraduate degree from Syracuse University and a graduate degree from the University of Kentucky.
Syed A. Jafry Syed A. Jafry is on the board of Zimmer Biomet Holdings, Inc. and Senior Vice President & President-Regions at Thermo Fisher Scientific, Inc. In his past career he occupied the position of President for Thermo Fisher Scientific (China) Co., Ltd. and President-GE Sensing Asia at GE (China) Co., Ltd. He received a graduate degree from the University of Massachusetts and an undergraduate degree from The University of Lahore.
Tony W. Collins Presently, Tony W. Collins occupies the position of Chief Accounting Officer, VP & Controller at Zimmer Biomet Holdings, Inc. and Vice President & Controller for LDR Holding Corp. (a subsidiary of Zimmer Biomet Holdings, Inc.). In his past career Mr. Collins held the position of Chief Financial Officer-Commercial Segment at Oshkosh Corp. and Chief Financial Officer & Finance Director at Guidant Japan KK. Mr. Collins received an undergraduate degree from Miami University and an MBA from the University of Michigan.
Sang Yi Sang Yi is President-APAC Region at Zimmer Biomet Holdings, Inc.
David J. Kunz Presently, David J. Kunz holds the position of VP-Global Quality, Clinical & Regulatory Affairs at Zimmer Biomet Holdings, Inc. Mr. Kunz previously held the position of Director-Supplier Quality Assurance at Boston Scientific Corp. and Director-Supplier Quality Assurance at Guidant Corp. (a subsidiary of Boston Scientific Corp.) and Vice President-Quality Assurance at Ecolab Corp. He received an undergraduate degree and an MBA from the University of Minnesota.
David J. Kunz Presently, David J. Kunz holds the position of VP-Global Quality, Clinical & Regulatory Affairs at Zimmer Biomet Holdings, Inc. Mr. Kunz previously held the position of Director-Supplier Quality Assurance at Boston Scientific Corp. and Director-Supplier Quality Assurance at Guidant Corp. (a subsidiary of Boston Scientific Corp.) and Vice President-Quality Assurance at Ecolab Corp. He received an undergraduate degree and an MBA from the University of Minnesota.
David J. Kunz Presently, David J. Kunz holds the position of VP-Global Quality, Clinical & Regulatory Affairs at Zimmer Biomet Holdings, Inc. Mr. Kunz previously held the position of Director-Supplier Quality Assurance at Boston Scientific Corp. and Director-Supplier Quality Assurance at Guidant Corp. (a subsidiary of Boston Scientific Corp.) and Vice President-Quality Assurance at Ecolab Corp. He received an undergraduate degree and an MBA from the University of Minnesota.
Zeeshan Tariq Currently, Zeeshan Tariq occupies the position of Chief Information Officer & Vice President for Zimmer Biomet Holdings, Inc. In the past Mr. Tariq held the position of Chief Information Officer & Vice President of Cardiovascular Group. He received an undergraduate degree from the University of Nebraska, a graduate degree from the University of Minnesota and an MBA from The Curtis L. Carlson School of Management.
Kenneth R. Tripp Kenneth R. Tripp occupies the position of Senior VP-Global Operations & Logistics at Zimmer Biomet Holdings, Inc. Mr. Tripp previously was Senior Vice President-Manufacturing at Cardinal Health, Inc. and Vice President-Patient Monitoring & Recovery at Medtronic, Inc. Kenneth R. Tripp received an undergraduate degree and an MBA from Ashford University LLC.
Angela Main Presently, Angela Main is Chief Compliance Officer & Senior Vice President at Zimmer Biomet Holdings, Inc.
Ivan Tornos Ivan Tornos is Group President-Orthopedics at Zimmer Biomet Holdings, Inc. In the past Mr. Tornos held the position of Vice President-Business Development at Baxter International, Inc., General Manager-Americas at Covidien Holding, Inc. and President-Europe, Middle East & Africa Regions at C.R. Bard, Inc. (New Jersey). Mr. Tornos received an MBA from the University of Miami School of Business and an undergraduate degree from Terry College of Business.
Pamela Puryear Pamela Puryear holds the position of Chief Human Resources Officer & Senior VP at Zimmer Biomet Holdings, Inc. In her past career she held the position of Senior Vice President & Chief Talent Officer at Pfizer Inc. and Chief Talent Officer & VP-Organization Development at Hospira, Inc. (a subsidiary of Pfizer Inc.). Pamela Puryear received an MBA from Harvard Business School and an undergraduate degree from Yale University.

量化对比

全部评论 0

  • 暂无评论

阿布量化公众号二维码 abu_quant 扫一扫关注阿布量化

热门推荐